- Pharmaceutical companies
- South America
- Ecuador
- Novartis
Novartis in Ecuador
Addresses:
-
Novartis Ecuador S.A., Av. Amazonas N37-39 y, Unión Nacional de Periodistas, Edificio Eurocenter - Piso 2, Quito, Ecuador
Phone: 593 2 399 0000
Fax: 593 2 399 0001
-
Novartis Ecuador S.A., Site Guayaquil, Av. Carlos Julio Arosemena Km 2.5 y las Monjas, Edificio Berlin - Piso 2, Guayaquil, Ecuador
Phone: 593 4 220 2700
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsEi vielä rekrytointiaMultippeliskleroosi, uusiutuva-remitoiva
-
Novartis PharmaceuticalsEi vielä rekrytointiaNivelreuma | Systeeminen lupus erythematosus | Sjögrensin tauti
-
Novartis PharmaceuticalsEi vielä rekrytointiaKohonnut Lp(a) ja todettu ateroskleroottinen sydän- ja verisuonisairaus
-
Novartis PharmaceuticalsRekrytointiMultippeliskleroosin uusiutuvat muodotEspanja
-
Novartis PharmaceuticalsRekrytointi
-
Novartis PharmaceuticalsEi vielä rekrytointia
-
Novartis PharmaceuticalsRekrytointiMultippeliskleroosi (MS)Ranska
-
Novartis PharmaceuticalsEi vielä rekrytointia
-
Novartis PharmaceuticalsRekrytointiHR+HER2 – pitkälle edennyt rintasyöpäVenäjän federaatio
-
Novartis PharmaceuticalsRekrytointiSepelvaltimotauti | Määrittämättömän potentiaalin klooninen hematopoiesis (CHIP)Saksa, Kanada
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.